Zhejiang Dayang Biotech Group Co Ltd
SZSE:003017
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
Z
|
Zhejiang Dayang Biotech Group Co Ltd
SZSE:003017
|
2.8B CNY |
Loading...
|
|
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
89.6B USD |
Loading...
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
86.6B USD |
Loading...
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
11.6T JPY |
Loading...
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
289.8B CNY |
Loading...
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
28.4B CHF |
Loading...
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
27.4B USD |
Loading...
|
|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK |
Loading...
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.3T INR |
Loading...
|
|
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR |
Loading...
|
|
| US |
|
Albemarle Corp
NYSE:ALB
|
21.1B USD |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Zhejiang Dayang Biotech Group Co Ltd
Glance View
Zhejiang Dayang Biotech Group Co., Ltd. engages in the production and sales of potassium salt and veterinary drugs. The company is headquartered in Hangzhou, Zhejiang and currently employs 925 full-time employees. The company went IPO on 2020-10-26. The firm's main products include potassium carbonate, potassium bicarbonate, amproline hydrochloride, 2-chloro-6-fluorobenzaldehyde, etc. Its products are used in food, pesticide, fertilizer, medicine and glass fields. The firm conducts its businesses within the Chinese market and to overseas markets.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Zhejiang Dayang Biotech Group Co Ltd is 9.9%, which is above its 3-year median of 7.5%.
Over the last 3 years, Zhejiang Dayang Biotech Group Co Ltd’s Net Margin has increased from 5.3% to 9.9%. During this period, it reached a low of 5.3% on Sep 30, 2022 and a high of 9.9% on Sep 30, 2025.
